About Gilead Sciences

Gilead Sciences, Inc., the sponsor of the Aztreonam Lysine for Inhalation Expanded Access Program, is a biopharmaceutical company dedicated to advancing the care of patients suffering from life-threatening diseases worldwide. Gilead is committed to creating respiratory therapeutics, including inhalation-based therapies for cystic fibrosis (CF) and respiratory infections.

For more information about Gilead and its products, please visit www.gilead.com.

The information contained on this site is intended for audiences in the United States only. The content on this site may not apply to non-U.S. audiences as regulatory control, legal requirements and/or medical practices may vary in other countries.

eFlow is a registered trademark of PARI Pharma GmbH.